Fosun Pharmaceutical bought Concert Pharmaceuticals Concert Pharmaceuticals from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Concert Pharmaceuticals

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

Write your comment first

News feed

Etalon Group sales in Q1 increased by 1.5%

4/25/25 ETLN

Samolet reported for 2024 by IFRS

4/25/25 SMLT

Yandex reported for 3 months of 2025 by IFRS

4/25/25 YDEX

Board of Directors of Perm Energy Supply Company recommended that dividends be paid for 2024

4/25/25 PMSB

Additional share issue will almost halve VK's dough

4/25/25 VKCO

OMZ reported for 2024 under IFRS

4/24/25 OMZZP

Arsagera MC reported for 2024 under IFRS

4/24/25 ARSA

MTS Bank to place 6.93 mln additional issue shares

4/24/25 MBNK

Fesco organized for the first time a direct ship call of a container ship to Indonesia

4/24/25 FESH

Teplant Vostok reported for 2024 by IFRS

4/24/25 PRFN